
IBM (IBM) Stock Forecast & Price Target
IBM (IBM) Analyst Ratings
Bulls say
IBM has demonstrated strong financial performance with organic constant currency (cc) revenue growth estimated at 7-8% year-over-year in its software segment, surpassing prior guidance, while overall revenue increased by 17% cc, driven by a robust mainframe product cycle that contributed significantly to hybrid infrastructure revenues. The company’s free cash flow (FCF) generation and improving execution have led to a higher relative valuation compared to the S&P 500, indicating a positive market perception of its defensive characteristics and growth potential. Additionally, ongoing initiatives, such as the integration of acquisitions and a forecasted 5%+ revenue growth for 2026, signal a promising trajectory for IBM as it capitalizes on its industry-leading position and emerging technology opportunities.
Bears say
The outlook on IBM's stock is negatively impacted by increased competition from emerging technologies, particularly from Anthropic's Claude Code tool, which threatens key revenue streams related to legacy systems. Moreover, updated forecasts indicate a projected revenue decline of approximately $1.16 billion for 2026, influenced by adverse foreign exchange rates and economic challenges, despite some offset from an early acquisition close. Additionally, uncertainties surrounding the mainframe product cycle and the effectiveness of recent software acquisitions further contribute to the potential for decreased financial performance.
This aggregate rating is based on analysts' research of IBM and is not a guaranteed prediction by Public.com or investment advice.
IBM (IBM) Analyst Forecast & Price Prediction
Start investing in IBM (IBM)
Order type
Buy in
Order amount
Est. shares
0 shares